Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
January 25, 2022
Patent Application Number
16642082
Date Filed
September 13, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Methods of inducing a safe immune response against respiratory syncytial virus (RSV) in a human subject in need thereof, including administering to the subject a composition including recombinant adenovirus including a nucleic acid encoding an RSV Fusion (F) protein including the amino acid sequence of SEQ ID NO: 1, and a pharmaceutically acceptable carrier, in a total dose of from about 1×1010 to about 2×1011 viral particles (vp), are described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
